A 144-week real-world outcomes of upadacitinib 30 mg for atopic dermatitis in poor responders to 15 mg

Journal of the American Academy of Dermatology 2026

View at publisher

Authors: Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

DOI: 10.1016/j.jaad.2026.02.100

Cited by: 1

References: 5

Fields of Study & Subjects

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Asthma and respiratory diseases

References 5